Pelvic inflammatory disease (PID)
3° Cephalosporins Macrolides | Haemophilus ducreyi | Painful chancroid | - |
Klebsiella granulomatis | Granuloma inguinale | Macrolides Doxycycline |
Treponema pallidum | Painless chancre Condyloma lata | Penicillin |
Chlamydia trachomatis | Discharge :: greenish-yellow Lymphogranuloma venereum (LGV) Pelvic inflammatory disease (PID) | Macrolides Doxycycline |
Gardnerella vaginalis | Discharge :: grayish & fishy | Metronidazole |
Candida albicans | Discharge :: white & curdy | -Conazoles |
Trichomonas vaginalis | Discharge :: greenish-yellow & frothy | Metronidazole |
HPV | Condyloma accumulata Verruca vulgaris | - |
HSV | Paniful ulcers | - |
Comparison Between Testicular Torsion and Epididymitis
| Testicular Torsion | Epididymitis |
Prehn sign | - | + |
Cremasteric reflex | - | + |
Blood flow | ↓ | ↑ |
Medications for BPH
Mechanism | Medication |
α1 antagonists | Tamsulosin Terazosin Doxazosin Prazosin |
5α-Reductase inhibitors | Finasteride |
Reproductive Tumors
Epithelial Tumors
- Serous cystadenoma
cystadenocarcinoma - Mucinous cystadenoma
cystadenocarcinoma - Endometrioid carcinoma
- Clear cell carcinoma
- Mixed cell carcinoma
- Transitional cell carcinoma [Brenner tumor]
- Carcinosarcoma [Malignant mixed Mullerian tumor (MMMT)]
Stromal Tumors
Female | Male | Markers |
Theca cell tumor [Thecoma] | Leydig cell tumor | - |
Granulosa cell tumor | Sertoli cell tumor | Inhibin |
Fibroma | Fibroma | - |
Germ Cell Tumors (GCT)
Female | Male | Markers |
Dysgerminoma | Seminoma | ALP & LDH |
Choriocarcinoma | Choriocarcinoma | hCG |
Endodermal sinus tumor (EST) | Endodermal sinus tumor (EST) | AFP |
Embryonal carcinoma | Embryonal carcinoma | hCG & AFP |
Teratoma | Teratoma | hCG & AFP |
Triad of Meigs Syndrome
- Ovarian fibroma
- Pleural effusion
- Ascites
Types of Endometrial Cancer
Type | 1 | 2 |
Histology | Endometrioid | Non-endometrioid |
Risk factors | Estrogen | - |
Prognosis | Favorable | Poor |
Bethesda System for Pap Smear Results
- Squamous cell abnormalities
- Atypical squamous cell (ASC)
- Low-grade squamous intraepithelial lesion (LSIL)
- High-grade squamous intraepithelial lesion (HSIL)
- Squamous cell carcinoma
- Glandular cell abnormalities
- Atypical glandular cell (AGC)
- Adenocarcinoma in situ (AIS)
- Adenocarcinoma
Management of Abnormal Pap Smear Results
Result | Age (years) | HPV | Management |
- | < 30 | ±/? | Routine screening |
- | > 30 | -/? | Routine screening |
- | > 30 | + | Repeat screening in 1 year |
ASC-US | < 25 | - | Routine screening |
ASC-US | < 25 | +/? | Repeat screening in 1 year |
ASC-US | > 25 | - | Repeat screening in 3 years |
ASC-US | > 25 | ? | Repeat screening in 1 year |
LSIL | < 25 | ±/? | Repeat screening in 1 year |
LSIL | > 25 | - | Repeat screening in 1 year |
Consecutive Otherwise | Any | ±/? | Colposcopy ± Biopsy |
Management of Cervical Intraepithelial Neoplasia (CIN)
CIN | Management |
I | Repeat screening in 1 year |
II III | Cryotherapy Laser ablation Conization Loop electrosurgical excision procedure (LEEP) |
Management of Seminoma
- Radical orchiectomy
- Radiotherapy
- Chemotherapy
Contraception Methods
- Barrier contraception
- Combined hormonal contraception
- Oral contraceptive pills (OCPs)
- Contraceptive patch
- contraceptive ring
- Depot medroxyprogesterone
- Progestin subdermal implant
- Intrauterine devices
- Progestin intrauterine device
- Copper intrauterine device
Side Effects of Combined Hormonal Contraception
- ↑ Thromboembolism
- ↑ Breast cancer
- ↓ Endometrial cancer
- ↓ Ovarian cancer
Contraindications to Combined Hormonal Contraception
- Age ≥ 35 years
Smoking ≥ 15 cigarettes/day - History of thromboembolism
- Active breast cancer
- Liver failure
- Migraines with aura
Contraindications to Intrauterine Device (IUD)
- Pregnancy
- Unexplained vaginal bleeding
- Endometrial cancer
- Cervical cancer
- Pelvic inflammatory disease (PID)
Indications for Assisted Reproductive Technology (ART)
Intrauterine Insemination (IUI)
- Cervical factors
- Male factors
- Donor sperms
In Vitro Fertilization (IVF)
- Tubal factors
- Donor eggs
- Genetic screening
- Failed intrauterine insemination (IUI)
Controlled Ovarian Hyperstimulation
Suppression of Spontaneous Ovulation
Protocol | Timing |
GnRH agonist long protocol | Last luteal phase |
GnRH agonist short protocol | Menstruation |
GnRH antagonist protocol | Leading follicle > 14 mm |
Ovulation Induction
- (Follicles > 18 mm) ≥ 2
- Estradiol per co-dominant follicle > 200 pg/mL
Mechanism | Medication |
GnRH agonists | Leuprolide |
hCG agonists | Choriogonadotropin |
Breast Imaging Reporting and Data System (BI-RADS)
Category | Interpretation | Management | Likelihood of cancer |
0 | Inconclusive | Repeat | - |
1 | Negative | Routine | 0 |
2 | Benign | Routine | 0 |
3 | Probably benign | Every 6 months | < 2% |
4 | Suspicious | Biopsy | 2 ~ 95% |
5 | Highly suggestive | Biopsy | > 95% |
6 | Biopsy-proven | - | - |
Breast Tumors
Epithelial Tumors
- Fibrocystic change
- Intraductal papilloma
- Ductal carcinoma in situ (DCIS)
Invasive ductal carcinoma (IDC) - Lobular carcinoma in situ (LCIS)
Invasive lobular carcinoma (ILC) - Medullary carcinoma
Stromal Tumors
- Fibroadenoma
- Phyllodes tumor
Molecular Subtypes of Breast Cancer
Subtype | Receptors | Mutations |
Luminal A | PR & ER | - |
Luminal B | PR & ER | - |
HER2-enriched | HER2 | - |
Basal-like | - | BRCA |
Claudin-low | - | BRCA |
Interferon-rich | - | BRCA |
Types of Flaps for Breast Reconstruction
- Transverse rectus abdominis myocutaneous (TRAM) flap
- Latissimus dorsi (LD) flap
- Deep inferior epigastric perforator (DIEP) flap
- Superficial inferior epigastric artery (SIEA) flap
- Gluteal flap
- Transverse upper gracilis (TUG) flap
- Profunda artery perforator (PAP) flap